China Universal Asset Management Company’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.7K Sell
2,393
-238
-9% -$6.76K ﹤0.01% 440
2026
Q1
$78.9K Buy
2,631
+275
+12% +$9.11K 0.01% 426
2025
Q4
$77K Sell
2,356
-155
-6% -$5K 0.01% 424
2025
Q3
$87K Sell
2,511
-465
-16% -$14.9K 0.01% 398
2025
Q2
$83.3K Buy
2,976
+45
+2% +$1.21K 0.01% 379
2025
Q1
$73.6K Sell
2,931
-31
-1% -$783 0.01% 386
2024
Q4
$81.5K Sell
2,962
-937
-24% -$26.1K 0.01% 414
2024
Q3
$112K Buy
3,899
+1,510
+63% +$41.1K 0.01% 350
2024
Q2
$59.2K Sell
2,389
-1,380
-37% -$39.2K 0.01% 345
2024
Q1
$121K Buy
3,769
+1,504
+66% +$55.9K 0.02% 351
2023
Q4
$92.1K Buy
2,265
+1,770
+358% +$65.1K 0.02% 293
2023
Q3
$17.1K Buy
495
+265
+115% +$10.3K 0.01% 310
2023
Q2
$9.35K Buy
230
+48
+26% +$1.96K ﹤0.01% 325
2023
Q1
$7.03K Buy
182
+46
+34% +$1.89K ﹤0.01% 336
2022
Q4
$6.04K Buy
136
+4
+3% +$168 ﹤0.01% 276
2022
Q3
$6K Buy
+132
New +$6.76K ﹤0.01% 250

Other funds holding LKFT

China Universal Asset Management Company's LKFT Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 9% in Q2 2026, selling an estimated $6.76K and leaving 2,393 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

China Universal Asset Management Company first reported a position in LKFT in Q3 2022 and has held it in 16 quarters since. The position peaked at $121K in Q1 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • China Universal Asset Management Company held 2,393 shares of Lakefront Biotherapeutics American Depositary Shares worth $71.7K as of Q2 2026.
  • China Universal Asset Management Company sold 238 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $6.76K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #440 holding.
  • China Universal Asset Management Company first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Lakefront Biotherapeutics American Depositary Shares position peaked at $121K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.